American Enterprise Institute for Public Policy Research
Comparative Effectiveness Research: The Need for a Uniform Standard
June 2009
Reconciling a new comparative effectiveness research (CER) agency with scientific standards established in existing regulations would enable government agencies to share a consistent framework for making decisions based on CER. It would provide the kind of level playing field and clear guidelines that are needed to spur medical product developers and private payers to generate more of their own comparative evidence.
Reprinted with the permission of the American Enterprise Institute for Public Policy Research, Washington, D.C.
得意分野
Suggested News & Insights
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional ScrutinyApril 22, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement FocusApril 15, 2026Sidley Represents AIP in Its US$1.272 Billion Acquisition of Avanos MedicalApril 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory